Effect of H1 receptor stimulation on coronary artery diameter in patients with variant angina: comparison with effect of acetylcholine
K Okumura,
H Yasue,
K Matsuyama,
K Matsuyama,
Y Morikami,
H Ogawa,
and
K Obata
Division of Cardiology, Kumamoto University Medical School, Japan.
It has been suggested that histamine is involved in the pathogenesis of coronary spasm but its exact role remains unclear. H1 receptor stimulation of the coronary artery was performed with a selective intracoronary infusion of histamine (2 micrograms/min) in 21 patients with variant angina after blockade of the H2 receptor with cimetidine (25 mg/kg) and its effect on the coronary artery diameter was examined. Intracoronary injection of acetylcholine was also performed in 19 of the 21 patients. Ergonovine (0.2 mg) was intravenously administered in one patient. The coronary artery diameter was measured with cinevideodensitometric analysis. A mean plasma histamine concentration in the coronary sinus increased from 4 x 10(-9) to 7 x 10(-8) M 5 min after histamine infusion into the left coronary artery (n = 18). Coronary spasm was induced in 6 patients (29%) with histamine, in 18 (95%) with acetylcholine and in 1 with ergonovine. The effect of histamine on the luminal diameter was analyzed at the site of spasm in the 26 coronary arteries in which spasm was induced by acetylcholine or ergonovine. Of the 20 coronary arteries with a normal arteriogram or a fixed stenosis less than or equal to 50% of luminal diameter, histamine decreased the diameter in 4, increased it in 14 (70%) and caused no change in 2; of the 6 coronary arteries with a fixed stenosis greater than or equal to 75%, histamine decreased the diameter in 5 and increased it in 1. In the coronary arteries in which spasm was not induced by either acetylcholine or ergonovine, histamine increased the diameter, especially in those without advanced atherosclerosis.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:

|
 |

|
 |
 
I. Rozenberg, S. H. M. Sluka, L. Rohrer, J. Hofmann, B. Becher, A. Akhmedov, J. Soliz, P. Mocharla, J. Boren, P. Johansen, et al.
Histamine H1 Receptor Promotes Atherosclerotic Lesion Formation by Increasing Vascular Permeability for Low-Density Lipoproteins
Arterioscler Thromb Vasc Biol,
May 1, 2010;
30(5):
923 - 930.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Tanimoto, K.-Y. Wang, Y. Murata, S. Kimura, M. Nomaguchi, S. Nakata, M. Tsutsui, and Y. Sasaguri
Histamine Upregulates the Expression of Inducible Nitric Oxide Synthase in Human Intimal Smooth Muscle Cells via Histamine H1 Receptor and NF-{kappa}B Signaling Pathway
Arterioscler Thromb Vasc Biol,
July 1, 2007;
27(7):
1556 - 1561.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. E. Stahli, H. Greutert, S. Mei, P. Graf, K. Frischknecht, M. Stalder, L. Englberger, A. Kunzli, L. Scharer, T. F. Luscher, et al.
Absence of histamine-induced nitric oxide release in the human radial artery: implications for vasospasm of coronary artery bypass vessels
Am J Physiol Heart Circ Physiol,
March 1, 2006;
290(3):
H1182 - H1189.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Steffel, A. Akhmedov, H. Greutert, T. F. Luscher, and F. C. Tanner
Histamine Induces Tissue Factor Expression: Implications for Acute Coronary Syndromes
Circulation,
July 19, 2005;
112(3):
341 - 349.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Li, C. Burkhardt, U.-R. Heinrich, I. Brausch, N. Xia, and U. Forstermann
Histamine Upregulates Gene Expression of Endothelial Nitric Oxide Synthase in Human Vascular Endothelial Cells
Circulation,
May 13, 2003;
107(18):
2348 - 2354.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Kawano, T. Motoyama, H. Yasue, N. Hirai, H. M. Waly, K. Kugiyama, and H. Ogawa
Endothelial function fluctuates with diurnal variation in the frequency of ischemic episodes in patients with variant angina
J. Am. Coll. Cardiol.,
July 17, 2002;
40(2):
266 - 270.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. H Chester
Mast cells feel the strain
Cardiovasc Res,
July 1, 2002;
55(1):
13 - 15.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Miyata, H. Shimokawa, T. Yamawaki, I. Kunihiro, X. Zhou, T. Higo, E. Tanaka, N. Katsumata, K. Egashira, and A. Takeshita
Endothelial Vasodilator Function Is Preserved at the Spastic/Inflammatory Coronary Lesions in Pigs
Circulation,
September 28, 1999;
100(13):
1432 - 1437.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kugiyama, H. Yasue, K. Okumura, H. Ogawa, K. Fujimoto, K. Nakao, M. Yoshimura, T. Motoyama, Y. Inobe, and H. Kawano
Nitric Oxide Activity Is Deficient in Spasm Arteries of Patients With Coronary Spastic Angina
Circulation,
August 1, 1996;
94(3):
266 - 272.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
T. Kuga, K. Egashira, M. Mohri, H. Tsutsui, Y. Harasawa, Y. Urabe, S. Ando, H. Shimokawa, and A. Takeshita
Bradykinin-Induced Vasodilation Is Impaired at the Atherosclerotic Site but Is Preserved at the Spastic Site of Human Coronary Arteries In Vivo
Circulation,
July 15, 1995;
92(2):
183 - 189.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G. S. O'Neil, A. H. Chester, C. J. Schyns, S. Tadjkarimi, J. R. Pepper, and M. H. Yacoub
Vascular reactivity of human internal mammary and gastroepiploic arteries
Ann. Thorac. Surg.,
December 1, 1991;
52(6):
1310 - 1314.
[Abstract]
[PDF]
|
 |
|
|